Man Group plc Buys 26,558 Shares of LivaNova PLC (NASDAQ:LIVN)

Man Group plc grew its holdings in shares of LivaNova PLC (NASDAQ:LIVN - Free Report) by 5.1% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 547,781 shares of the company's stock after purchasing an additional 26,558 shares during the period. Man Group plc owned 1.01% of LivaNova worth $25,368,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of LIVN. Russell Investments Group Ltd. grew its holdings in LivaNova by 17.1% in the 4th quarter. Russell Investments Group Ltd. now owns 1,502 shares of the company's stock worth $70,000 after buying an additional 219 shares in the last quarter. Sterling Capital Management LLC grew its position in LivaNova by 800.6% in the fourth quarter. Sterling Capital Management LLC now owns 1,621 shares of the company's stock worth $75,000 after buying an additional 1,441 shares during the last quarter. Vestcor Inc bought a new position in shares of LivaNova in the fourth quarter valued at $204,000. Optimize Financial Inc acquired a new stake in shares of LivaNova during the 4th quarter valued at $208,000. Finally, Corton Capital Inc. acquired a new position in shares of LivaNova in the 4th quarter worth $214,000. Institutional investors and hedge funds own 97.64% of the company's stock.

Analyst Upgrades and Downgrades

LIVN has been the subject of a number of recent analyst reports. StockNews.com lowered shares of LivaNova from a "strong-buy" rating to a "buy" rating in a research note on Thursday, May 8th. The Goldman Sachs Group decreased their target price on LivaNova from $64.00 to $55.00 and set a "buy" rating for the company in a research report on Monday, March 3rd. Mizuho dropped their price target on LivaNova from $70.00 to $60.00 and set an "outperform" rating on the stock in a research report on Wednesday, February 26th. Barclays reduced their price objective on LivaNova from $56.00 to $55.00 and set an "equal weight" rating for the company in a research note on Thursday, May 8th. Finally, Needham & Company LLC reaffirmed a "buy" rating and set a $64.00 target price on shares of LivaNova in a research note on Tuesday, May 13th. One research analyst has rated the stock with a hold rating, seven have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Buy" and a consensus target price of $59.29.

LivaNova Stock Down 1.7%

LIVN traded down $0.79 during midday trading on Wednesday, hitting $44.10. 119,349 shares of the company's stock traded hands, compared to its average volume of 645,408. The company has a debt-to-equity ratio of 0.46, a current ratio of 3.37 and a quick ratio of 2.87. The company has a market cap of $2.40 billion, a PE ratio of 105.04 and a beta of 0.84. The stock's fifty day simple moving average is $38.61 and its 200-day simple moving average is $44.76. LivaNova PLC has a one year low of $32.48 and a one year high of $61.94.

LivaNova Company Profile

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.